refer
method
diagnosi
bloodstream
infect
blood
cultur
follow
biochem
identif
antibiot
suscept
test
isol
pathogen
process
requir
hour
rapid
administr
appropri
antimicrobi
treatment
crucial
surviv
septic
patient
therefor
rapid
method
enabl
diagnosi
directli
analysi
blood
sampl
without
cultur
need
recent
develop
platform
coupl
broadrang
pcr
amplif
pathogen
dna
electrospray
ioniz
mass
spectrometri
pcresim
abil
identifi
virtual
microorgan
direct
clinic
specimen
date
two
clinic
evalu
pcresim
technolog
diagnosi
bloodstream
infect
whole
blood
publish
discuss
describ
recent
improv
result
enhanc
sensit
commerci
avail
assay
molecular
diagnosi
bloodstream
infect
whole
blood
also
review
use
highli
sensit
molecular
diagnost
method
combin
convent
procedur
could
substanti
improv
manag
septic
patient
bloodstream
infect
lifethreaten
condit
result
presenc
microorgan
gener
bacteria
fungi
blood
time
window
administr
appropri
therapi
less
hour
symptom
recogn
optim
administ
broadrang
antibiot
within
first
hour
prefer
obtain
blood
cultur
microbiolog
diagnosi
inadequ
antimicrobi
therapi
increas
risk
mortal
everi
hour
delay
initi
appropri
antimicrobi
therapi
increas
mortal
patient
septic
shock
convent
method
microbiolog
diagnosi
sepsi
reli
blood
cultur
follow
biochem
identif
usual
take
day
obtain
identif
antimicrobi
suscept
profil
pathogen
major
limit
blood
cultur
method
requir
median
timetoposit
hour
anoth
limit
method
presenc
uncultur
fastidi
microorgan
may
decreas
sensit
cultur
may
also
neg
antimicrobi
therapi
begun
prior
blood
sampl
thu
urgent
need
improv
diagnost
tool
better
manag
septic
patient
ideal
diagnost
platform
identifi
broad
spectrum
pathogen
bacteria
fungi
virus
protozoa
determin
suscept
batteri
antibiot
allow
analysi
specimen
high
low
throughput
low
cost
per
sampl
minimum
handson
time
user
friendli
ideal
gener
result
time
manner
manag
septic
patient
hour
less
mass
spectrometri
technolog
recent
introduc
clinic
microbiolog
laboratori
use
matrixassist
laser
ioniz
timeofflight
malditof
spectromet
diagnost
process
may
shorten
identif
pathogen
achiev
within
minut
directli
posit
blood
cultur
addit
technolog
abl
detect
resist
antibiot
presenc
lactamas
includ
carbapenemas
methicillinresist
staphylococcu
aureu
even
vancomycinresist
enterococcu
spp
howev
technolog
reli
cultur
therefor
median
delay
unavoid
order
acceler
diagnost
process
desir
detect
ident
pathogen
directli
patient
blood
avoid
cultur
step
sever
molecular
method
develop
detect
pathogen
mainli
bacteria
fungi
whole
blood
first
assay
develop
design
detect
singl
pathogen
interest
review
klouch
singlepathogen
approach
use
diagnosi
bloodstream
infect
infect
may
caus
broad
rang
microorgan
limit
overcom
sever
commerci
assay
abl
detect
number
microorgan
assay
base
two
main
strategi
identif
select
group
pathogen
use
specif
target
ie
septifast
vyoo
magicplex
detect
broad
rang
pathogen
use
universalconserv
target
ie
sepsitest
pcresim
use
whole
blood
assay
design
detect
pathogen
nucleic
acid
challeng
excess
human
dna
may
hamper
detect
pathogen
genom
materi
may
inhibit
pcr
reaction
hemoglobin
trace
may
also
inhibit
pcrbase
amplif
therefor
molecular
method
forc
use
rel
small
volum
blood
ml
wherea
convent
cultur
method
use
ml
limit
volum
reduc
sensit
molecular
method
addit
bacteri
load
adult
bloodstream
infect
low
cfuml
may
preclud
detect
pathogen
dna
pcresim
technolog
combin
broadrang
pcr
amplif
electrosprayion
timeofflight
mass
spectrometri
highli
sensit
detect
method
method
develop
allow
use
pcresim
technolog
whole
blood
sampl
two
clinic
evalu
system
recent
publish
new
version
instrument
present
design
improv
sensit
implement
clinic
laboratori
review
describ
current
statu
molecular
diagnosi
sepsi
emphasi
pcresim
technolog
presenc
resist
gene
meca
may
detect
separ
test
initi
volum
blood
requir
ml
use
manual
dna
extract
protocol
ml
aliquot
process
duplic
ml
use
autom
dna
extract
region
amplifi
assay
intern
transcrib
spacer
region
ist
locat
ribosom
gene
bacteria
ribosom
gene
fungi
amplif
perform
lightcycl
instrument
differ
pathogen
detect
specif
fluoresc
probe
timetoresult
use
approach
hour
assay
wide
evalu
clinic
set
howev
result
conflict
report
sensit
rang
icu
patient
recent
chang
et
al
review
avail
literatur
report
use
septifast
assay
perform
metaanalysi
includ
data
patient
select
studi
overal
calcul
sensit
septifast
confid
interv
specif
confid
interv
perform
test
clearli
vari
depend
group
patient
test
sepsitest
assay
base
broadrang
pcr
amplif
follow
sequenc
sepsitest
two
ml
aliquot
blood
process
duplic
human
dna
select
degrad
prior
bacteri
cell
lysi
step
sever
studi
use
approach
diagnosi
sepsi
publish
largest
studi
report
sensit
specif
two
smaller
studi
report
lower
valu
sensit
specif
vyoo
assay
multiplex
pcr
analysi
detect
pathogen
includ
six
speci
candida
aspergillu
fumigatu
well
sever
resist
gene
methicillin
resist
gene
meca
vancomycin
resist
gene
vana
vanb
lactamas
gene
blashv
blactxm
amplifi
product
visual
use
convent
gel
electrophoresi
timetoresult
hour
assay
microbi
dna
ml
blood
enrich
total
dna
appli
affin
chromatograph
column
specif
bind
microbi
dna
looxter
addit
human
dna
deplet
extract
step
assay
sensit
rang
magicplex
sepsi
assay
three
pcr
reaction
necessari
achiev
identif
speci
level
pathogen
first
convent
pcr
amplif
step
perform
step
primer
design
amplifi
genom
materi
microorgan
bacteria
five
speci
candida
aspergillu
fumigatu
three
resist
gene
methicillin
resist
gene
meca
vancomycin
resist
gene
vana
vanb
use
realtim
pcr
carri
screen
step
identif
group
genera
level
pathogen
present
final
second
realtim
pcr
perform
achiev
identif
speci
level
identif
bacteri
speci
five
candida
speci
aspergillu
fumigatu
possibl
dna
extract
ml
whole
blood
use
human
dna
remov
prior
lysi
microorgan
timetoresult
assay
hour
knowledg
one
studi
use
approach
molecular
diagnosi
sepsi
publish
sensit
specif
report
respect
principl
technolog
technolog
combin
broadrang
pcr
esim
mass
spectrometri
briefli
pcr
amplicon
desalt
analyz
mass
spectrometri
esim
use
determin
molecular
mass
amplicon
use
calcul
base
composit
amplicon
base
composit
multipl
amplicon
differ
region
genom
compar
extens
databas
identif
pathogen
achiev
figur
even
though
base
composit
analysi
inform
sequenc
enough
discrimin
power
detect
identif
hundr
microbi
pathogen
broad
bacteria
candida
detect
assay
bac
assay
ibi
bioscienc
abbott
compani
carlsbad
ca
usa
design
use
clinic
research
identifi
bacteria
candida
speci
bac
assay
also
detect
resist
gene
three
clinic
relev
antibiot
methicillin
meca
vancomycin
vana
vanb
carbapenem
blakpc
amplif
conserv
region
genom
wide
use
identif
microorgan
speci
level
although
common
target
ribosom
dna
gene
ie
bacteria
fungi
sever
housekeep
gene
ie
tufb
rplb
valss
rpob
also
use
identif
pathogen
within
gene
highli
conserv
region
use
prime
site
region
amplifi
contain
enough
variabl
discrimin
speci
instanc
order
identifi
bacteri
candida
speci
bac
assay
includ
thirteen
pair
primer
target
differ
conserv
region
nine
primer
pair
bacteria
four
candida
speci
advantag
use
pcr
primer
design
sever
conserv
region
vari
degre
specif
one
microorgan
present
redund
coverag
across
variou
primer
pair
especi
relev
differ
microorgan
present
differ
abund
use
sever
nonoverlap
primer
pair
may
allow
amplif
less
abund
speci
redund
amplif
also
prevent
miss
detect
due
mismatch
singl
prime
site
mass
spectrometri
highli
sensit
detect
small
amount
nucleic
acid
given
sequenc
even
complex
mixtur
pcresim
system
employ
softwar
algorithm
calcul
base
composit
amplicon
base
mass
compar
extens
databas
achiev
identif
pathogen
anoth
featur
technolog
allow
rel
quantif
microorgan
present
specimen
achiev
use
intern
standard
amplifi
primer
pair
amplif
target
gene
intern
standard
differ
base
composit
thu
differenti
synthet
standard
ad
pcr
well
known
copi
number
comparison
standard
microbi
dna
permit
quantif
absenc
pcr
product
intern
standard
serv
pcr
posit
control
exclud
pcr
inhibit
accuraci
bac
assay
diagnosi
bloodstream
infect
first
evalu
blood
cultur
specimen
studi
demonstr
robust
technolog
term
accuraci
identif
howev
introduct
malditof
instrument
identif
pathogen
posit
blood
cultur
base
proteinpeptid
profil
becam
clear
pcresim
would
abl
compet
either
timetoresult
costpersampl
basi
malditof
advantag
pcresim
assay
rel
malditof
assay
pcresim
optim
achiev
rapid
diagnosi
direct
clinic
specimen
date
two
clinic
evalu
pcresim
diagnosi
bloodstream
infect
whole
blood
publish
jordanalluch
et
al
evalu
system
analyz
whole
blood
specimen
pair
posit
blood
cultur
neg
blood
cultur
result
laffler
et
al
test
whole
blood
specimen
posit
pair
blood
cultur
neg
blood
cultur
result
agreement
blood
cultur
follow
biochem
identif
pcresim
good
studi
jordanalluch
et
al
studi
laffler
et
al
studi
polymicrobi
infect
detect
studi
convent
andor
molecular
method
agreement
method
specimen
low
mix
infect
detect
one
two
method
howev
use
molecular
method
addit
blood
cultur
would
result
addit
detect
clinic
relev
microorgan
case
could
influenc
patient
outcom
number
case
studi
pcresim
detect
microorgan
whole
blood
specimen
pair
neg
blood
cultur
clinic
relev
addit
detect
microorgan
investig
clinic
record
review
order
discrimin
probabl
contamin
true
pathogen
proport
detect
microorgan
clinic
signific
isol
convent
method
system
gather
inform
obtain
primer
pair
blood
cultur
neg
case
blood
cultur
neg
case
find
highli
relev
convent
method
abl
diagnos
etiolog
infect
cultureneg
patient
sensit
system
calcul
use
differ
approach
studi
jordanalluch
et
al
disregard
specimen
polymicrobi
identif
either
method
event
one
correct
detect
disagr
second
one
difficult
catalogu
true
posit
fals
posit
term
sensit
pcresim
laffler
et
al
perform
theoret
approxim
sensit
base
histor
blood
cultur
posit
rate
center
extrapol
experiment
obtain
pcresim
posit
rate
order
obtain
number
neg
blood
cultur
process
pcresim
would
addit
test
posit
estim
sensit
pcresim
use
theoret
approach
extrapol
may
led
bias
estim
sensit
although
sensit
valu
directli
compar
calcul
differ
way
laffler
et
al
studi
higher
detect
rate
pcresim
whole
blood
specimen
pair
posit
blood
cultur
mani
factor
may
affect
sensit
molecular
method
direct
comparison
studi
difficult
differ
clinic
condit
patient
characterist
eg
age
antimicrobi
treatment
time
blood
draw
microorgan
isol
number
blood
cultur
taken
volum
blood
drawn
cultur
may
result
differ
studi
limit
sensit
evalu
version
pcresim
technolog
result
amount
blood
test
comparison
blood
cultur
versu
ml
problem
overcom
new
version
pcresim
technolog
use
higher
volum
whole
blood
reduc
limit
detect
sinc
origin
descript
team
ibi
bioscienc
pcresim
technolog
continu
evolv
first
instrument
name
tiger
triangul
identif
genet
evalu
risk
initi
design
biodefens
surveil
applic
due
capabl
identifi
previous
unknown
uncultur
microorgan
shortli
commerci
version
technolog
appear
ibi
format
sampl
process
autom
softwar
system
permit
manag
instrument
signal
analysi
report
gener
version
instrument
intend
use
health
industri
set
provid
highli
sensit
detect
without
need
highli
train
oper
incorpor
ibi
bioscienc
abbott
group
system
upgrad
system
plexid
use
aforement
studi
recent
newer
version
develop
improv
focus
analysi
direct
patient
specimen
one
princip
chang
use
larger
volum
blood
ml
order
increas
sensit
chang
extract
process
allow
biom
research
intern
pcresim
assay
abl
differenti
speci
mycobacterium
tuberculosi
complex
classifi
speci
base
drug
resist
technolog
also
prove
use
epidemiolog
propos
given
enabl
molecular
genotyp
instanc
genotyp
staphylococcu
aureu
acinetobact
baumannii
respiratori
pathogen
moreov
technolog
show
great
promis
global
surveil
influenza
viru
remark
abl
detect
novel
strain
influenza
viru
outbreak
without
modif
influenza
surveil
assay
ibi
bioscienc
carlsbad
ca
usa
fungi
caus
agent
infect
due
slow
growth
microorgan
identif
cultur
often
impract
recent
new
assay
pcresim
system
valid
detect
aspergillu
spp
candida
spp
pneumocysti
spp
cryptococcu
spp
mucor
spp
rhizopu
spp
concord
rate
pcresim
phenotyp
identif
sequenc
genu
level
speci
level
although
experi
studi
perform
refer
strain
clinic
isol
detect
aspergillu
terreu
directli
cultureneg
bronchioalveolar
lavag
demonstr
microbiolog
diagnosi
histor
reli
cultur
isol
causal
agent
provid
irrefut
proof
infect
allow
pathogen
identif
determin
antibiot
suscept
howev
mani
microorgan
uncultur
fastidi
slowgrow
addit
prior
antimicrobi
treatment
neg
affect
culturebas
test
case
bloodstream
infect
lack
detect
critic
signific
percentag
blood
cultur
neg
despit
high
likelihood
bacteri
fungal
infect
lack
cultur
time
answer
mean
mani
septic
patient
appropri
treat
pcresim
robust
technolog
offer
rapid
altern
diagnosi
bloodstream
well
infect
although
current
commerci
avail
new
present
technolog
improv
sever
aspect
significantli
enhanc
sensit
main
advantag
technolog
use
direct
patient
specimen
avoid
cultur
step
use
technolog
complement
convent
method
offer
real
improv
manag
septic
critic
ill
patient
ie
patient
suffer
mening
fever
unknown
origin
versatil
detect
differ
kind
microorgan
make
technolog
highli
valuabl
tool
clinic
laboratori
